Back to company

ENDOGEN ApS: Financial statements 2014

CVR: 29813337

ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 18,625 and a net result of DKK -36,822 compared with DKK -14,190 the year before. The profit margin was -197.7%. Equity amounted to DKK 70,093. The solvency ratio was 100%.

Revenue
18,625 kr.
Gross Profit
-36,293 kr.
Profit/Loss
-36,822 kr.
Equity
70,093 kr.
Total Assets
70,093 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201419 t.-36 t.-37 t.70 t.-
20130-14 t.-14 t.107 t.-
20120-990-1 t.121 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on ENDOGEN ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

ENDOGEN ApS: The 2013 annual report is outMar 14, 2014

ENDOGEN ApS has published its annual report for 2013. Revenue came to DKK 0, and the net result was DKK -14,190.

About ENDOGEN ApS

ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity amounted to DKK -82,428.